Skip to content

Heel-unloading Orthosis for Treatment of Calcaneus Fractures

The Effect of a Heel-unloading Orthosis in Short-term Treatment of Calcaneus Fractures on Physical Function, Quality of Life and Return to Work - a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03572816
Acronym
CALCFRO
Enrollment
50
Registered
2018-06-28
Start date
2018-08-01
Completion date
2021-12-31
Last updated
2018-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcaneus Fracture, Orthopedic Devices Associated With Misadventures

Brief summary

Treatment of acute calcaneus fractures includes non- or partial weight bearing, but protocols are different and often not very specific. In fact, there are no studies published comparing different procedures or special supporting devices. Recently, a heel-unloading orthosis ('Settner shoe') was introduced, allowing walking by shifting the load to the middle- and forefoot. Specifically in calcaneus fractures, early regain of physical activity has been highlighted as one of the key factors for quality of life and the ability to return to work. Thus, the investigators hypothesize that mobilization with the 'Settner shoe' results in higher physical activity within the first 3 months and secondly improves ability to return to work in calcaneus fracture patients aged 18-60 years.

Detailed description

In the past decades, the scientific focus regarding calcaneus fractures was the choice of operative or non-operative treatment modality. Although the evidence is ambiguous, recent meta-analyses suggest that operative therapy is associated with a higher likelihood to resume pre-injury work, to reach a higher level of physical function and fewer problems when wearing shoes. However, non-operative therapy has significant less complications and infections. Typically, aftercare includes non- or partial weight bearing, but protocols are different and often not very specific. In fact, there are no studies published comparing different procedures or special supporting devices. Recently, a heel-unloading orthosis ('Settner shoe') was introduced in aftercare for calcaneus fractures, allowing walking by shifting the load to the middle- and forefoot. This orthosis does not only enable early mobilization of patients suffering one-sided fractures, but also permits going following two-sided fractures, avoiding the otherwise necessary wheel-chair mobilization. The 'Settner shoe' can be applied in non-operative therapy and following operations. Specifically in calcaneus fractures, early regain of physical activity has been highlighted as one of the key factors for quality of life and the ability to return to work. Thus, the investigators hypothesize that mobilization with the 'Settner shoe' results in higher physical activity within the first 3 months and secondly improves ability to return to work in calcaneus fracture patients aged 18-60 years. Further outcome criteria are the American Orthopaedic Foot and Ankle Society's (AOFAS) ankle-hindfoot assessment, a 3-dimensional gait analysis, and the EQ-5D-3L questionnaire. It is the first trail applying a standardized aftercare in patients suffering from calcaneus fractures aiming to improve the non-operative part of treatment. Furthermore, the trial clarifies, whether the economical effort for the equipment acquisition is scientifically justified. The investigators hypothesize that mobilization with the 'Settner shoe' results in higher physical activity within the first 3 months after calcaneus fractures. Research questions Does the application of a heel-unloading orthosis ('Settner shoe') independent of operative or non-operative therapy of a calcaneus fracture improve: 1. the physical activity (active minutes per day)? 2. the quality of life (EQ-5D-3L)? 3. the foot function (AOFAS)? 4. the time necessary for return to work in patients between 18 and 60 years?

Interventions

DEVICESettner shoe

custom-made heel-unloading orthosis ('Settner shoe') in aftercare of calcaneus fractures (used according to manufacturer), certified 'CE' product with more than 10 years experience

Sponsors

University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study design is a parallel group, randomized controlled trial with open allocation including all patients with calcaneus fractures independent of kind of initial therapy.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Fracture of the calcaneus, which is classifiable according to the Sanders' classification (excludes avulsion fractures) * Being able to understand Danish or English and answer the questionnaires * Informed consent

Exclusion criteria

* Pathological fractures * Immature skeletal system * Other fractures with influence on weight-bearing * A soft-tissue situation not allowing the equipment with a 'Settner shoe' within 3 weeks after treatment (either decision-making for non-operative therapy or open reduction and internal fixation)

Design outcomes

Primary

MeasureTime frameDescription
activity3 monthsthe number of active minutes per day

Secondary

MeasureTime frameDescription
QoL3 monthsthe EuroQol 5D-3L questionnaire following
activity6 monthsthe number of active minutes per day

Other

MeasureTime frameDescription
Range of motion (ROM)3 monthsPro- and supination (percent of healthy side or assumed normal mobility) are analyzed.
AOFAS3 monthsfunctional foot score, The American Orthopedic Foot and Ankle Score, includes pain, function, alignment, for AOFAS calculation the subscores are added, ranges between 0 (worst) and 100 (best) points
pain3 monthsThe subjective pain of patients is assessed using a Visual Analog Scale (VAS) in combination with registration of their pain medication, which is classified according to the WHO pain ladder. The Summary Pain Score (SPS) is calculated from the sum of the two components. VAS 0 (best) - 10 (worst) WHO scale for pain medication 0 (best, lowest) - 5 (worst, highest)
Gait3 months3-dimensional gait analysis
Work6 monthstime point of return to work

Countries

Denmark

Contacts

Primary ContactHagen Schmal, Prof
hagen.schmal@rsyd.dk+45 2942 8705
Backup ContactLasse Pedersen, MD
Lasse.Pedersen@rsyd.dk+45 6541 3560

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026